Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Peter Silberstein, MD
Chief of medical oncology
Creighton University
Published Articles (1)
Prostate Cancer in 2026: Perioperative Therapy, Biomarker-Driven Combinations, and Permission to Pause Treatment
August 11, 2026
Four developments from this year's ASCO meeting reshape decision-making across the prostate cancer spectrum, from the operating room to the metastatic setting.